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The diagnostic and therapeutic difficulties of the recurrent lower 
respiratory tract infections in children with neurological disorders
Trudności w diagnostyce i leczeniu zakażeń dolnych dróg oddechowych  u dzieci z chorobami 
neurologicznymi
Ewa Jamroz, Bożena Kordys-Darmolińska, Ewa Głuszkiewicz, Halina Woś
ABSTRACT 
Background and aims. Severe clinical course of the respiratory tract infections is very frequent in children with 
neurological disorders. The aim of this study was to establish the diagnostic and therapeutic procedures giving the 
best results in this group of children.
Methods. The symptoms, clinical picture, diagnostics, treatment an outcome of lower respiratory system infections in 
children with neurological disorders were analyzed. The patients, according to the type of neurological dysfunction, 
were divided into 5 groups: progressive encephalophaties, cerebral palsy, developmental delay, chromosomal anomalies 
and other dysmorphic syndromes, neuromuscular diseases. The patients were analyzed according to: lower respiratory 
tract infections risk factors, diagnostic signs of acute lower respiratory tract infections, outcome and treatment.
Results. In the study group the most numerous were children with cerebral palsy and with progressive encephalopaties. 
Those patients required target, broad-spectrum antibiotic therapy, intensive chest physiotherapy, energetic and 
metabolic deficits supplementation, using prokinetics and careful administration of mucolitics.
Conclusions. In the treatment of the respiratory tract diseases in children with neurological disorders cooperation of 
pneumologist, neurologist, gastrologist and physioterapeutist is necessary.
Keywords: cerebral palsy, progressive encephalophaties, neuromuscular diseases, neurologically disabled children, lower re-
spiratory tract infections
STReSzCzenie
Wstęp. Przebieg zakażeń układu oddechowego u dzieci z zaburzeniami neurologicznymi często jest bardzo ciężki, a 
rokowanie niepewne. Celem badania była próba ustalenia procedur diagnostycznych i terapeutycznych w nawracają-
cych infekcjach dróg oddechowych w tej grupie pacjentów.
Cel. Ciężki przebieg kliniczny zakażeń dróg oddechowych jest bardzo częsty u dzieci z zaburzeniami neurologicznymi. Ce-
lem badania było ustalenie procedur diagnostycznych i terapeutycznych, które dają najlepsze efekty w tej grupie dzieci.
Materiał i metody. W zależności od rodzaju schorzenia neurologicznego pacjentów podzielono na 5 grup: z postę-
pującymi encefalopatiami, mózgowym porażeniem dziecięcym, opóźnieniem rozwoju psychoruchowego, aberracja-
mi chromosomalnymi i innymi zaburzeniami dysmorficznymi oraz z chorobami nerwowo-mięśniowymi.W analizie 
uwzględniono czynniki ryzyka, objawy, diagnostykę, terapię i wyniki leczenia nawracających zakażeń dróg oddecho-
wych u dzieci z przewlekłymi zaburzeniami neurologicznymi.
Wyniki. W leczeniu chorób układu oddechowego u dzieci z zaburzeniami neurologicznymi niezbędna jest ścisła współ-
praca pulmonologa, gastrologa i fizjoterapeuty. 
Wnioski. W leczeniu chorób układu oddechowego u dzieci z zaburzeniami neurologicznymi niezbędna jest ścisła 
współpraca pneumologa, neurologa, gastrologa i fizjoterapeuty.
Słowa kluczowe: mózgowe porażenie dziecięce, postępująca encefatopatia, choroby nerwowo-mięśniowe, zakażenie dol-
nych dróg oddechowych
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introduction
The recurrent respiratory tract infections are the most 
common diseases in childhood. In younger children 
they occur 6 to 8 times a year. Their frequency 
decreases with age; older children become ill less 
frequently, and adults get sick 2 to 4 times a year [1]. 
Recurrent infections are associated with the 
process of maturation of the respiratory and 
immunological systems, the way of feeding early in 
the life, the moment of first infection, frequency of 
subsequent infections and exposure to noxious agents 
in the environment, mainly passive smoking. Many of 
those factors are related to the socioeconomic status 
[1, 2]. Recurrent infections in children without any 
additional health troubles are rather mild diseases; 
however, pneumonia is one of the most frequent 
causes of hospitalization among the youngest 
children, reaching 40% of all admissions to hospitals. 
In developing countries, lower respiratory tract 
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infections are the fifth main death reason of children 
younger than 5 years [2, 3]. 
Feeding difficulties, often accompanied by 
gastroesophageal reflux (GER) belong to the most 
important factors increasing relapse frequency 
and hampering the successful treatment of lower 
respiratory tract infections [4, 5]. 
A severe clinical course of acute lower respiratory 
tract diseases is very frequent in children with 
neurological disorders; however this common clinical 
experience is not sufficiently recorded in the literature 
[6, 7]. Pneumonia can often be lethal in this group of 
patients, among severely disabled children, up to 80% 
of deaths is caused by respiratory problems [7, 8].
Although it is a common clinical knowledge that 
children with neurological impairment often have 
respiratory problems, frequency rates have not been 
estimated. Retrospective prevalence of pneumonias 
estimates about 31% per 6 months; from 38% single 
episodes to 19% recurrent pneumonias per year 
[9]. 
A number of factors contribute to respiratory 
difficulties in handicapped children; several of these 
issues coexist and may interact with each other. Many 
disorders as bronchopulmonary dysplasia (BPD), 
malnutrition, dysphagia, GER, chest wall and spinal 
deformities, some antiepileptic and myorelaxant 
drugs as well as several others have been considered 
as lower respiratory infections contributing factors 
in this group of children [6,8]. Although most of 
these factors occur in all handicapped children, 
their relative importance varies between particular 
groups of patients [10–17]. In this paper, we tried 
to find the most important differences in clinical 
practice. 
The aim of this study was to establish diagnostic 
and therapeutic procedures giving the best results 
in this group of children. The authors analyzed the 
clinical course, diagnostics, outcome and treatment 
of lower respiratory tract infections in children with 
chronic neurological disorders. 
Materials and Methods
The group consisted of 72 children, 30 girls and 42 
boys, aged from 2 months to 17 years (mean age 
3.4 years), with a chronic neurological disorders 
and recurring lower respiratory tract infections, 
hospitalized in the Pulmological and Neurological 
Wards of Silesian Medical University School.  
According to the type of neurological dysfunction, 
the patients were divided into 5 groups (Tab. I):
1.  Progressive encephalophaties (PE) n=23 (32%), 
aged from 2 months to 13 years (mean age 2.7 
years). Into this group patients with following 
diseases were included: globoid cell leukodystrophy 
(n=1), GM1 gangliosidosis (n=2), metachromatic 
leukodystrophy (n=1), Niemann-Pick type A disease 
(n=1), mucopolisacharidosis (n=2), bifunctional 
protein deficiency (n=1), nonketotic hiperglicynemia 
(n=3), ethylomalonic aciduria (n=1), hydantoin-5-
propionic aciduria (n=1), Canavan disease (n=2), 
congenital disorders of glycosylation (n=2), ornithine 
carbamylase deficiency (n=1), mitochondrial 
encephalomyopathy (n=4) and progressive 
encephalopathy of unknown origin (n=1). 
2.  Cerebral palsy (CP); n=20 (28%), aged 1.5–17 years 
(mean age 5.7 years). There were 12 patients with 
spastic diplegia, 4 with hemiplegia and 4 with 
athetoid quadriplegia. 
3.  Developmental delay (DD); n=12 (17%), aged 2–13 
months (mean age 6 months).
4.  Chromosomal anomalies and other dysmorphic 
syndromes (CAODS) n=11; (15%) aged 7 months–6 
years (mean age 2.5 years). This group comprised 
children with: Down syndrome (n=4), Turner 
syndrome (n=1), Angelman syndrome (n=3), Rett 
syndrome (n=1) and Wolf-Hirshorn syndrome (n=2). 
5.  Neuromuscular diseases (ND) n=6 (8%), aged 6 
months–15 years (mean age 5.3 years). Into this 
group patients with spinal muscular atrophy 
(n=2), muscular progressive dystrophy (n=2) and 
polyneuropathies (n=2) were included. 
The patients were analyzed according to:
1.  Risk factors for recurrent lower respiratory tract 
infections: 
a.  Perinatal pathology: congenital pneumonia, 
bronchopulmonary dysplasia (BPD), respiratory 
distress in the neonatal period, congenital heart 
defects. 
b.  Factors due to underlying neurological disorder: 
muscular hypotonia, chest wall deformity 
causing retention of secretion in the airways, 
some antiepileptic and myorelaxant drugs.
c.  Other factors intensifying respiratory 
disturbances: malnutrition, gastroesophageal 
reflux (GER), hypoproteinemia. 
Table I. Types of neurological dysfunction 
Tabela I. Rodzaje zaburzeń neurologicznych
Type of neurological dysfunction n (%)
Progressive encephalopathies 23 (32%)
Cerebral palsy 20 (28%)
Developmental delay 12 (17%)
Chromosomal anomalies and other various 
dysmorphic syndromes 11 (15%)
Neuromuscular disease 6 (8%)
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d.  Colonization of the respiratory tract by 
pathological flora
2.  Diagnostic signs of acute lower respiratory tract 
infections: clinical symptoms (cough, tachypnoe, 
dyspnoea, cyanosis), physical examination 
(decreased breath sounds, rales or wheezes), 
laboratory findings and X-ray examination. 
3.  Outcome of the lower respiratory tract infections.
4.  Treatment. 
Results 
In the study group, children with PE (n=23; 32%) 
and CP (n=20; 28%) were the most numerous, and 
the least frequent were patients with neuromuscular 
diseases (n=6; 8%). 
As the risk factors of recurrent lower respiratory 
tract infections, perinatal disorders, including 
respiratory distress syndrome, congenital pneumonia, 
BPD and congenital heart defects were analysed. 
Respiratory distress syndrome was the most frequent 
in children with DD (n=8; 67%) and CP (n=12; 60%). 
Also congenital pneumonia was most often diagnosed 
in children with DD (n=8; 67%) and CP (n=10; 50%), 
whereas less frequently – in children with PE. BPD 
was the most frequent in the group of children with 
CP (n=7; 35%). 
A congenital heart defects were most frequent in 
the group of children with CAODS (82%), whereas 
they did not occur in the groups with PE, DD and 
ND. A relatively high incidence of respiration distress 
in the neonatal period in children with CAODS may 
be associated with the presence of other congenital 
defects (mainly heart, respiratory and gastrointestinal 
system). Perinatal pathology was not observed in the 
group with neuromuscular diseases (Tab. II). 
Among factors determining the recurrence 
of respiratory tract infections resulting from a 
neurological condition: muscular hypotonia, 
weakness of respiratory muscles, adverse drug 
reactions (some antiepileptic and myorelaxant 
medicines) were analysed. Muscular hypotonia 
occurred most often in children with ND (n=5; 
95%) and with EP (n=18; 85%); least frequent was 
in patients with CP. Chest deformation was most 
often observed in the group with ND (n=4; 66%), 
least frequent was in the group with DD (n=2; 
16%); in the other groups chest deformities were 
found in approx. 40% of children. The antiepileptic 
and myorelaxant drugs (mainly benzodiazepines 
and phenobarbital) were applied in children in all 
groups, except for ND, most often in patients with 
CP and PE (Tab. III). 
The factors promoting recurrent infections of 
the lower respiratory tract include: the body mass 
deficiency (most severe in the groups with PE; n=17; 
Table II. Perinatal pathology 
Tabela II. Patologia okresu ciążowo-porodowego
Study group Respiratory 
distress
Congenital 
pneumonia
Congenital 
heart defects BPD
Progressive encephalopathies 9 (43%) 2 (10%) 4 (13%) 2 (9%)
Cerebral palsy 12 (60%) 10 (50%) 3 (15%) 7 (35%)
Developmental delay 8 (67%) 8 (67%) 0 2 (16%)
Chromosomal anomalies and other various dysmorphic 
syndromes 6 (55%) 2 (18%) 9 (82%) 2 (18%)
Neuromuscular diseases 0 0 0 0
Table III. Incidence of neurological disorders 
Tabela III. Częstość występowania zaburzeń neurologicznych
Study group Muscular 
hypotonia
Medication Chest 
deformation
Progressive encephalopathies 18 (85%) 13 (62%) 7 (33%)
Cerebral palsy 4 (20%) 12 (60%) 9 (45%)
Developmental delay 9 (75%) 5 (42%) 2 (16%)
Chromosomal anomalies and other various dysmorphic syndromes 7 (63)% 4 (36%) 5 (45%)
Neuromuscular diseases 5 (95%) 0 4 (66%)
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74% and CAODS; n=8; 73%), gastroesophageal reflux 
and hypoproteinemia. GER was most frequently 
diagnosed in children with DD (n=8; 67%) and 
with PE (n=11; 48%). A high GER incidence in the 
first group may be connected with the age range 
and the existence of physiological reflux and in the 
patients. Hypoproteinemia was most often observed 
in the group with PE (n=10; 43%). An important 
factor responsible for the recurrence of respiratory 
tract infections is colonization of the airways by 
pathogenic flora. Such colonization was most often 
observed in children with neuromuscular diseases, 
which mainly resulted from a long-term course of 
the underlying disease and frequent hospitalizations 
(also in the intensive care units), due to a severe 
course of infections (Tab. IV).
The relapses of lower respiratory tract infections 
in children with neurological diseases manifested as 
respiration disorders with dyspnoea. Radiologically 
confirmed pneumonia was most often diagnosed in 
children with PE and ND. Dyspnoea was the least 
frequent in children with CP. 
The recurrent lower respiratory tract infections in 
children with chronic neurological disorders often had 
a severe course and led to respiratory and circulatory 
insufficiency, mainly in patients with PE and ND. 
Circulatory failure, present mostly in children with 
PE, mainly with mitochondrial encephalomyopathies, 
lysosomal diseases and congenital disorders of 
glycosylation, was probably due to cardiomyopathy 
seen in those patients (Tab. V).
Lower respiratory tract infections required an 
intense treatment based on antibiotics, systemic 
corticosteroids, mucolytics, cardiovascular drugs and 
aerosol therapy. Corticosteroids were most often used 
in the groups of children with PE and DD (Tab. VI).
Antireflux management was most frequently 
introduced in the group with DD and PE. Albumin 
infusions were necessary mainly in children with PE 
and CAODS.
Discussion
Respiratory tract infections belong to the most 
common diseases in children. In younger patients 
morbidity is much higher than in older ones [18]. 
In developing countries, respiratory tract infections 
belong to main death causes of children under the 
age of 5. Pneumonia is a reason for hospitalization 
in 40% infants, still remains a serious health 
problem, especially in the youngest children and in 
so called ‘high risk groups’ including children with 
neurological diseases [2, 4, 9, 19]. Diagnostic and 
therapeutic difficulties concerning pneumonia in the 
youngest children, are potentiated by the course and 
complications of the underlying neurological disease 
[6, 7, 10–17].
Epidemiological data suggest that viruses, mainly 
rhinoviruses, are principal pathogens causing 
respiratory tract infections in children [1, 3]. Bacterial 
superinfections usually follow a primary viral 
disease. This type of infection is caused mainly by 
Table IV. Incidence of factors intensifying respiratory disturbances 
Tabela IV. Częstość występowania czynników nasilających zaburzenia układu oddechowego
Type of dysfunction Ger n (%) Malnutrition n (%)
Hipoproteinemia 
n (%)
Study group 31 (43%) 43 (60%) 20 (28%)
Progressive encephalopathies 11 (48%) 17 (74%) 10 (43%)
Cerebral palsy 8 (40%) 9 (45%) 2 (10%)
Developmental delay 8 (67%) 5 (42%) 3 (25%)
Chromosomal anomalies and other various dysmorphic syndromes 2 (18%) 8 (73%) 4 (36%)
Neuromuscular diseases 2 (33%) 4 (67%) 1 (17%)
Table V. Outcome of the lower respiratory tract infections 
Tabela V. Powikłania infekcji dolnych dróg oddechowych
Study group Progressive ence-
phalopathies
Cerebral palsy Developmental 
delay
Chromosomal anoma-
lies and other various 
dysmorphic syndromes
Neuromuscular 
diseases
Respiratory failure 16 (65%) 3 (15%) 4 (33%) 4 (36%) 4 (67%)
Circulatory failure 8 (48%) 1 (5%) 1 (8%) 4 (36%) 2 (33%)
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Streptococcus pneumoniae, Haemophilus influenzae, 
Staphylococcus aureus and Moraxella catarrhalis. 
Mycoplasma pneumoniae and Chlamydia pneumoniae 
should also be considered as pathogenic factors [18].
In patients with neurological disorders, pneumonia 
often develops on the base of chronic inflammation 
caused by neonatal respiratory disorders, airway 
colonization by pathogens, cardiovascular and 
respiratory congenital defects, muscular hypotonia, 
spine and chest deformity and increasing mucous 
retention in the airways [2, 6, 20]. 
Physical examination in contrast to symptoms 
and radiographic findings, usually reveals minimal 
abnormalities for these pneumoniae. The evaluation 
of respiratory murmur during physical examination 
is hindered by common in most children auscultatory 
changes connected with bronchopulmonary dysplasia, 
airway flaccidity or obturation accompanying GER. It 
is also necessary to differentiate between crepitation 
and fine rales – these sounds occur not only during 
inflammation, but also in circulatory insufficiency 
and transudates due to hypoalbuminemia [1, 10, 11, 
13, 21]. 
There are not many publications regarding 
recurrent respiratory system infections in children 
with impairment of the nervous system, analysing 
not only the well-known and extensively discussed 
risk factors, but also a relationship between recurrent 
pneumonias and the nature of underlying neurological 
disease, like in the presented study. 
In the study group, the most numerous were patients 
with PE and CP, while the least frequent were those 
with ND. Our results differ from data reported by other 
authors. Sullivan et al investigated children with severe 
neurological impairment and recurrent pneumonias, 
between their patients almost three quarters had 
cerebral palsy [22]. Also in studies conducted by Mahon 
and Kibirige majority of patients (62%) was diagnosed 
as suffering from cerebral palsy [9]. A large number 
of patients with progressive encephalopathies in our 
study, despite a low incidence of these diseases in 
the whole population, are most likely associated with 
frequent hospitalizations in our tertiary referral centers 
due to increasing neurological disability, coexistence 
of refractory epilepsy and recurrent infections of the 
lower respiratory tract. A relatively small size of the 
group with ND is due to an early diagnosis, often 
before the full clinical manifestation of characteristic 
for this group muscular hypotonia. In the case of 
severe respiratory tract infections, patients with ND 
are usually treated in paediatric departments, and if 
respiratory insufficiency occurs, in the intensive care 
units [23, 24]. 
Between risk factors for recurrent pneumonias 
we analyzed: perinatal pathology affecting also the 
respiratory system and issues increasing respiratory 
disturbances related to an underlying neurological 
disorder. In children with DD and CP, in which the 
CNS pathology is often a consequence of foetus and 
infant exposure to hypoxia, BPD, respiratory distress 
syndrome and congenital pneumonia, were the most 
common. Seddon at al also found a very high incidence 
of perinatal pathology in patients with cerebral palsy 
and recurrent pneumonia [7].
Respiratory muscles weakness leads to a 
progressive chest deformity and kyphoscoliosis. It 
causes reductions in lung volume, chest wall and 
lung compliance, ventilation/perfusion imbalances, 
hypoxemia, hypercapnia and central hypoventilation. 
Scoliosis which developed prior to the completion of 
lung growth causes reduced number and complexity 
of alveoli as well as increased alveolar size, factors that 
contribute to diminished lung volume, ventilation/
perfusion imbalances, and hypoxemia. Pulmonary 
arterial hypertension occurring with scoliosis results 
from hypoxic vasoconstriction and pulmonary 
vascular remodeling [23, 24]. Scoliosis causes mucus 
retention, enabling its superinfection and secondary 
destruction of pulmonary vessels, lungs and bronchi 
[24]. Chest deformation was most often observed in 
Table VI. Treatment of the lower respiratory tract infections 
Tabela VI. Leczenie zakażeń dolnych dróg oddechowych
Study group Polytherapy >14 days Systemic 
corticosteroids
Aerosolotherapy Mucolitics
Progressive 
encephalopathies 18 (74%) 20 (83%) 18 (78%) 15 (65%) 3 (13%)
Cerebral palsy 10 (50%) 12 (60%) 7 (35%) 10 (50%) 12 (60%)
Developmental delay 7 (58%) 6 (50%) 6 (50%) 8 (67%) 3 (25%)
Chromosomal anomalies 
and other various 
dysmorphic syndromes
9 (82%) 9 (82%) 3 (27%) 8 (73%) 8 (73%)
Neuromuscular diseases 5 (83%) 4 (67%) 2 (33%) 5 (83%) 5 (83%)
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the group with ND, where muscular hypotonia was 
most expressed, whereas least frequently was in the 
group with DD, which probably resulted from the age 
of patients – up to the end of the first year of life. 
In the other groups chest deformities were found in 
approx. 40% of children. Similar results that chest 
wall deformity occurs in majority of patients with 
neuromuscular diseases were also presented by other 
authors, e.g. Healy, Mahon, Paschoal [7, 9, 24].
For some, not completely understood and 
researched reasons, GER appears to be more common, 
persistent, and severe in children with neurological 
impairment [6, 22, 25]. Neurological dysfunction 
and coexisting GER lead to vomiting, impairment of 
ventilation and aspiration of chyme. Any material 
which refluxes may not be actively cleared as a result 
of disturbed peristalsis, and is more likely to be 
aspirated. As well as predisposing to chest infections, 
reflux episodes may provoke profound apnea and 
laryngeal spasm. Seddon and Khan estimated the 
incidence of GER in cerebral palsy from 32% to 75% 
[7]. In turn, Sullivan et al found GER in 1/3 of patients 
with chronic serious neurological impairment [22]. 
In our group GER was present in 43% of children, 
most frequently was diagnosed in patients with DD 
(67%) and with PE (48%). A high incidence in the first 
group may be connected with the age range and the 
existence of physiological reflux and in some of these 
patients. 
A severe course of lower respiratory tract infections 
increases malnutrition, determined by, among others, 
the degree of nervous system dysfunction. According 
to Healy malnutrition affects 40–80% of children with 
neurological diseases. Among our patients the body 
mass deficiency was present in 60%, most often in the 
groups with PE and CAODS. Malnutrition subjects the 
respiratory muscles to catabolism, leading to atrophy, 
weakness and reduced lung function; it also enables 
bacterial colonization of the airways and alters a 
resistance to infections. In such cases, cooperation 
between a gastrologist, physiotherapist and speech 
therapist is also necessary [6, 10, 11, 13, 19, 24]. 
The anamnesis frequently reveals in patients with 
neurological dysfunction prolonged hospitalizations 
in neonatal period [2, 5, 7, 21]. In these patients 
pneumonia is caused by endogenic or nosocomial 
pathogens. Gram-negative bacteria (E. coli, Klebsiella 
pneumoniae, Pseudomonas aeruginosa, H.influenzae) 
and also Staphylococcus aureus MRSA, Streptococcus 
pneumoniae, Mycoplasma, Chlamydia pneumoniae, 
Legionella, Acinetobacter as well as viruses are 
very common pathogens in this group of patients 
[20]. Third generation cephalosporins, imipenems, 
fluoroquinolones with aminoglycosides, vancomycin 
and macrolides should be used in treatment of lower 
respiratory tract infections in such cases [19, 21, 
23]. Pneumonia caused by RS virus often can be 
lethal in neurologically handicapped children, so in 
the treatment of recurrent lower respiratory tract 
infection application of Syntagis should be considered, 
especially in children with BPD syndrome [19].
Our findings indicate that in children with PE 
and neuromuscular diseases, the course of lower 
respiratory tract infections is the most severe. In these 
patients there are numerous coexisting factors that 
significantly hinder effective treatment. In children 
with EP, the most important factors involve: muscle 
hypotonia, malnutrition, adverse effects of used 
medicines, GER and hypoproteinemia. 
The significance of individual risk factors of 
recurrent lower respiratory tract infections is different 
in children with neuromuscular diseases, where a 
predominant factor is muscle hypotonia, followed by 
chest deformity, malnutrition and colonization of the 
airways by pathological flora. 
Our findings not only enrich the knowledge 
on lower respiratory tract infections in children 
with chronic neurological disorders, but also have 
significant practical implications since they indicate 
the main problems in the treatment of respiratory 
tract infections in children with nervous system 
dysfunction.  
Conclusions
A complex treatment of recurrent lower respiratory 
tract infections in children with chronic diseases of 
the nervous system should include:
1.  Elimination of deficiencies and disturbances 
such as hypoproteinemia, energy deficiency 
or electrolyte imbalance and the concomitant 
treatment of other systemic dysfunctions, e.g. GER 
or cardiovascular conditions.
2.  Broad-spectrum antibiotic therapy aimed at 
anaerobic and aerobic bacteria (due to a tendency 
to aspirate chyme).
3.  Administration of systemic corticosteroids in the 
acute phase of disease. 
4.  Administration of β2 mimetics, cholinolytics and 
corticosteroids in nebulisation. 
5.  Careful administration of mucolytics and 
hypertonic saline, depending on patient’s 
neurological condition.
6.  Kinezytherapy to improve the evacuation of retained 
mucus and to prevent further deformities. 
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